ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1264

Quality of Life in Patients with SAPHO Syndrome: A Single-center Survey of 588 Patients

Zhaohui Li 1, Chen Li2, Yihan Cao 3, Yirong Xiang 1, Yueting Li 4 and Wen Zhang 5, 1Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, Beijing, China (People's Republic), 2Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, Beijing, China (People's Republic), 3Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, China (People's Republic), 4Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College; The Ministry of Education Key Laboratory, Beijing, China, Beijing, China (People's Republic), 5Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China (People's Republic)

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: SAPHO syndrome and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Miscellaneous Rheumatic & Inflammatory Disease Poster II: Autoinflammation Related Diseases & Therapies

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare autoimmune disease with heterogeneous presentation and severe disease burden. Factors influencing the quality of life (QoL) in patients with SAPHO syndrome remained under-recognized. We aim to assess the impact of various current symptoms (osteoarticular, dermatological and nail) on QoL in SAPHO patients.

Methods: A cross-sectional survey was conducted based on a previously established single-center dynamic cohort of SAPHO syndrome.1, 2 Electronic questionnaires were distributed to patients recruited from January 2004 and December 2018 via a patient committee. Patients with active disease were asked to report their current clinical presentation (osteoarticular, dermatological and nail) and fill out the EuroQol five dimensions questionnaire (EQ-5D). Health related quality of life results measured by the EQ-5D were converted to a utility score using the Chinese time trade-off value set.3 In addition, for those with osteoarticular manifestations, disease activity was measured using Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The Dermatology Quality of Life Index (DLQI) was obtained from the patients with dermatological manifestations. 

Results: A total of 588 questionnaires were issued and 521 were retrieved. 60 were in remission at the time of examination. For the EQ-5D dimensions, patients reported the most problems (of any level) with pain or discomfort (52.6% [95% CI 48•0–57.2]) and fewest problems with self-care (10.1% [7.6–13•2]). Patients with current osteoarticular symptoms had a significant lower EQ-5D score than those without, which remained significant after adjustment for covariates (age, gender, smoking, and BMI). Meanwhile, such a relationship was not shown for dermatological and nail manifestations. For patients with skin lesions, DLQI was significantly lower at the presence of osteoarticular symptoms or nail lesions, even after adjusting for covariates.

Conclusion:

Our findings suggested a negative correlation between osteoarticular symptoms and QoL in SAPHO syndrome. Effectively controlling osteoarticular symptoms may be pivotal in improving patient QoL. Nail involvement, which is under-recognized previously, also had a negative influence on QoL in SAPHO patients.

References:

  1. Li C et al. Rheumatology (Oxford). 2016;55(6):1023-30.
  2. Cao Y et al. Semin Arthritis Rheum. 2019;48(6):990-6.
  3. Liu GG et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014;17(5):597-604.

Table 1 Basic characteristics of patients included in the study

Figure 1 EQ-5D for patients with and without osteoarticular symptoms

Table 2 Correlations between the quality of life and variables


Disclosure: Z. Li, None; C. Li, None; Y. Cao, None; Y. Xiang, None; Y. Li, None; W. Zhang, None.

To cite this abstract in AMA style:

Li Z, Li C, Cao Y, Xiang Y, Li Y, Zhang W. Quality of Life in Patients with SAPHO Syndrome: A Single-center Survey of 588 Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/quality-of-life-in-patients-with-sapho-syndrome-a-single-center-survey-of-588-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quality-of-life-in-patients-with-sapho-syndrome-a-single-center-survey-of-588-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology